We found that, indeed, the ZsG+ DTCs in both liver and lung in 3-month allograft tumors were consistently Vcam1-negative while tumor cells in the overt lung metastases had high levels of Vcam1 (Fig. 4F). This evidence concerns the gene VCAM1 and neoplasm.